TABLE OF CONTENTS

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Middle East & Africa Infectious Disease Therapeutics Market - Key Market Dynamics

4.1 Middle East & Africa Infectious Disease Therapeutics Market - Key Market Dynamics

4.2 Market Drivers

4.2.1 Rising Prevalence of Infectious Disease

4.2.2 Increasing Focus on Funding and R&D in Infectious Disease Therapeutics

4.3 Market Restraints

4.3.1 Emergence of Anti-infective Drugs Resistance and Associated Side Effects

4.4 Market Opportunities

4.4.1 Escalating Threat of Antibiotic Resistance

4.5 Future Trends

4.5.1 Rising Number of Product Approvals and Launches

4.6 Impact of Drivers and Restraints:

5. Infectious Disease Therapeutics Market - Middle East & Africa Market Analysis

5.1 Middle East & Africa Infectious Disease Therapeutics Market Revenue (US$ Million), 2022-2030

6. Middle East & Africa Infectious Disease Therapeutics Market Analysis - by Drug Class

6.1 Overview

6.2 Anti-Viral

6.2.1 Overview

6.2.2 Anti-viral: Middle East & Africa Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

6.3 Anti-bacterial

6.3.1 Overview

6.3.2 Anti-bacterial: Middle East & Africa Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

6.4 Anti-fungal

6.4.1 Overview

6.4.2 Anti-fungal: Middle East & Africa Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

6.5 Others

6.5.1 Overview

6.5.2 Others: Middle East & Africa Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

7. Middle East & Africa Infectious Disease Therapeutics Market Analysis - by Indication

7.1 Overview

7.2 HIV

7.2.1 Overview

7.2.2 HIV: Middle East & Africa Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

7.3 Hepatitis

7.3.1 Overview

7.3.2 Hepatitis: Middle East & Africa Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

7.4 Tuberculosis

7.4.1 Overview

7.4.2 Tuberculosis: Middle East & Africa Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

7.5 Influenza

7.5.1 Overview

7.5.2 Influenza: Middle East & Africa Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

7.6 HPV

7.6.1 Overview

7.6.2 HPV: Middle East & Africa Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

7.7 Others

7.7.1 Overview

7.7.2 Others: Middle East & Africa Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

8. Middle East & Africa Infectious Disease Therapeutics Market Analysis - by Route of Administration

8.1 Overview

8.2 Oral

8.2.1 Overview

8.2.2 Oral: Middle East & Africa Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

8.3 Parenteral

8.3.1 Overview

8.3.2 Parenteral: Middle East & Africa Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

8.4 Topical

8.4.1 Overview

8.4.2 Topical: Middle East & Africa Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

8.5 Others

8.5.1 Overview

8.5.2 Others: Middle East & Africa Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

9. Middle East & Africa Infectious Disease Therapeutics Market Analysis - by Distribution Channel

9.1 Overview

9.2 Hospital Pharmacies

9.2.1 Overview

9.2.2 Hospital Pharmacies: Middle East & Africa Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

9.3 Retail Pharmacies

9.3.1 Overview

9.3.2 Retail Pharmacies: Middle East & Africa Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

9.4 Others

9.4.1 Overview

9.4.2 Others: Middle East & Africa Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

10. Middle East & Africa Infectious Disease Therapeutics Market - Country Analysis

10.1 Middle East & Africa Infectious Disease Therapeutics Market

10.1.1 Middle East & Africa Infectious Disease Therapeutics Market - Revenue and Forecast Analysis - by Country

10.1.1.1 Middle East & Africa: Infectious Disease Therapeutics Market - Revenue and Forecast Analysis - by Country

10.1.1.2 South Africa: Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.1 Overview

10.1.1.3 Saudi Arabia: Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.1 Saudi Arabia: Infectious Disease Therapeutics Market Breakdown, by Drug Class

10.1.1.3.2 Saudi Arabia: Infectious Disease Therapeutics Market Breakdown, by Indication

10.1.1.3.3 Saudi Arabia: Infectious Disease Therapeutics Market Breakdown, by Route of Administration

10.1.1.3.4 Saudi Arabia: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel

10.1.1.4 South Africa: Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.4.1 Overview

10.1.1.5 South Africa: Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.5.1 South Africa: Infectious Disease Therapeutics Market Breakdown, by Drug Class

10.1.1.5.2 South Africa: Infectious Disease Therapeutics Market Breakdown, by Indication

10.1.1.5.3 South Africa: Infectious Disease Therapeutics Market Breakdown, by Route of Administration

10.1.1.5.4 South Africa: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel

10.1.1.6 United Arab Emirates: Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.6.1 Overview

10.1.1.7 United Arab Emirates: Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.7.1 United Arab Emirates: Infectious Disease Therapeutics Market Breakdown, by Drug Class

10.1.1.7.2 United Arab Emirates: Infectious Disease Therapeutics Market Breakdown, by Indication

10.1.1.7.3 United Arab Emirates: Infectious Disease Therapeutics Market Breakdown, by Route of Administration

10.1.1.7.4 United Arab Emirates: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel

10.1.1.8 Rest of Middle East & Africa: Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.8.1 Overview

10.1.1.9 Rest of Middle East & Africa: Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.9.1 Rest of Middle East & Africa: Infectious Disease Therapeutics Market Breakdown, by Drug Class

10.1.1.9.2 Rest of Middle East & Africa: Infectious Disease Therapeutics Market Breakdown, by Indication

10.1.1.9.3 Rest of Middle East & Africa: Infectious Disease Therapeutics Market Breakdown, by Route of Administration

10.1.1.9.4 Rest of Middle East & Africa: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel

11. Infectious Disease Therapeutics Market-Industry Landscape

11.1 Overview

11.2 Growth Strategies in the Infectious Disease Therapeutics Market

11.3 Inorganic Growth Strategies

11.3.1 Overview

11.4 Organic Growth Strategies

11.4.1 Overview

12. Company Profiles

12.1 Pfizer Inc

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Gilead Sciences Inc

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 F. Hoffmann-La Roche Ltd

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Bayer AG

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 GSK Plc

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 AbbVie Inc

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Merck & Co Inc

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 Astellas Pharma Inc

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

13. Appendix

13.1 About The Insight Partners

List of Tables

Table 1. Middle East & Africa Infectious Disease Therapeutics Market Segmentation

Table 2. Middle East & Africa Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million) - by Drug Class

Table 3. Middle East & Africa Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million) - by Indication

Table 4. Middle East & Africa Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration

Table 5. Middle East & Africa Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel

Table 6. Middle East & Africa: Infectious Disease Therapeutics Market - Revenue and Forecast to 2030(US$ Million) - by Country

Table 7. Saudi Arabia: Infectious Disease Therapeutics Market - Revenue and Forecast to 2030(US$ Million) - by Drug Class

Table 8. Saudi Arabia: Infectious Disease Therapeutics Market - Revenue and Forecast to 2030(US$ Million) - by Indication

Table 9. Saudi Arabia: Infectious Disease Therapeutics Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration

Table 10. Saudi Arabia: Infectious Disease Therapeutics Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel

Table 11. South Africa: Infectious Disease Therapeutics Market - Revenue and Forecast to 2030(US$ Million) - by Drug Class

Table 12. South Africa: Infectious Disease Therapeutics Market - Revenue and Forecast to 2030(US$ Million) - by Indication

Table 13. South Africa: Infectious Disease Therapeutics Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration

Table 14. South Africa: Infectious Disease Therapeutics Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel

Table 15. United Arab Emirates: Infectious Disease Therapeutics Market - Revenue and Forecast to 2030(US$ Million) - by Drug Class

Table 16. United Arab Emirates: Infectious Disease Therapeutics Market - Revenue and Forecast to 2030(US$ Million) - by Indication

Table 17. United Arab Emirates: Infectious Disease Therapeutics Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration

Table 18. United Arab Emirates: Infectious Disease Therapeutics Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel

Table 19. Rest of Middle East & Africa: Infectious Disease Therapeutics Market - Revenue and Forecast to 2030(US$ Million) - by Drug Class

Table 20. Rest of Middle East & Africa: Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million) - by Indication

Table 21. Rest of Middle East & Africa: Infectious Disease Therapeutics Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration

Table 22. Rest of Middle East & Africa: Infectious Disease Therapeutics Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel

Table 23. Recent Inorganic Growth Strategies in the Infectious Disease Therapeutics Market

Table 24. Recent Organic Growth Strategies in the Infectious Disease Therapeutics Market

List of Figures

Figure 1. Middle East & Africa Infectious Disease Therapeutics Market Segmentation, by Country

Figure 2. Impact Analysis of Drivers and Restraints

Figure 3. Middle East & Africa Infectious Disease Therapeutics Market Revenue (US$ Million), 2022-2030

Figure 4. Middle East & Africa Infectious Disease Therapeutics Market Share (%) - by Drug Class (2022 and 2030)

Figure 5. Anti-viral: Middle East & Africa Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 6. Anti-bacterial: Middle East & Africa Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 7. Anti-fungal: Middle East & Africa Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. Others: Middle East & Africa Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 9. Middle East & Africa Infectious Disease Therapeutics Market Share (%) - by Indication (2022 and 2030)

Figure 10. HIV: Middle East & Africa Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. Hepatitis: Middle East & Africa Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 12. Tuberculosis: Middle East & Africa Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 13. Influenza: Middle East & Africa Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 14. HPV: Middle East & Africa Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 15. Others: Middle East & Africa Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 16. Middle East & Africa Infectious Disease Therapeutics Market Share (%) - by Route Of Administration (2022 and 2030)

Figure 17. Oral: Middle East & Africa Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 18. Parenteral: Middle East & Africa Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 19. Topical: Middle East & Africa Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 20. Others: Middle East & Africa Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 21. Middle East & Africa Infectious Disease Therapeutics Market Share (%) - by Distribution Channel (2022 and 2030)

Figure 22. Hospital Pharmacies: Middle East & Africa Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 23. Retail Pharmacies: Middle East & Africa Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 24. Others: Middle East & Africa Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 25. Middle East & Africa Infectious Disease Therapeutics Market, by Key Country - Revenue (2022) (US$ Million)

Figure 26. Middle East & Africa Infectious Disease Therapeutics Market Breakdown, by Key Countries, 2022 and 2030 (%)

Figure 27. Saudi Arabia: Infectious Disease Therapeutics Market - Revenue and Forecast to 2030(US$ Million)

Figure 28. South Africa: Infectious Disease Therapeutics Market - Revenue and Forecast to 2030(US$ Million)

Figure 29. United Arab Emirates: Infectious Disease Therapeutics Market - Revenue and Forecast to 2030(US$ Million)

Figure 30. Rest of Middle East & Africa: Infectious Disease Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 31. Growth Strategies in the Infectious Disease Therapeutics Market